Duck Creek Technologies Unveils the Next Generation of Data Management and Analytics with the Launch of Duck Creek Clarity™

The company’s newest product introduction will transform the future of data-driven excellence for the insurance industry BOSTON, Dec. 05, 2023 (GLOBE NEWSWIRE) — Duck Creek Technologies, the intelligent solutions provider defining the future of property and casualty (P&C) and general insurance, announces the release of Duck Creek ClarityTM, an innovative, cloud-native technology solution and the […]

Read More »

STX Group Launches Working Capital Solution to Accelerate Renewable Energy Transition

New SPV introduces innovative way to provide funding to environmental commodities markets Amsterdam, Dec. 05, 2023 (GLOBE NEWSWIRE) — AMSTERDAM (December 5, 2023) – STX Group, a leading environmental markets and climate solutions firm, today announces the launch of a working capital solution, specifically designed for environmental certificates. The launch comes as a response to the increased requirements […]

Read More »

LeddarTech and Prospector Capital Corp. Announce Effectiveness of Registration Statement and December 13, 2023 Extraordinary General Meeting to Approve Business Combination

QUEBEC CITY, Dec. 04, 2023 (GLOBE NEWSWIRE) — LeddarTech Inc.® (“LeddarTech” or the “Company”), an automotive software company that provides patented disruptive AI-based low-level sensor fusion and perception software technology for ADAS and AD, and Prospector Capital Corp. (“Prospector”) (NASDAQ: PRSR, PRSRU, PRSRW), a publicly traded special-purpose acquisition company led by former Qualcomm President Derek […]

Read More »

Zenas BioPharma Strengthens Executive Leadership with Appointment of Jennifer Fox as Chief Business Officer and Chief Financial Officer and Tanya Fischer, M.D., PhD. as Head of R&D and Chief Medical Officer

Expanded strategic and operational leadership positions Zenas for growth as obexelimab advances in late-stage clinical trials for multiple potential I&I indications WALTHAM, Mass., Dec. 04, 2023 (GLOBE NEWSWIRE) —  Zenas BioPharma, a global biopharmaceutical company committed to becoming a leader in the development and commercialization of inflammation and immunology (I&I) directed therapies, today announced the […]

Read More »